Special report: The Fierce 50 of 2024

hereditary angioedema

chop down cut tree chainsaw ax
Biotech

Pharming uproots angioedema gene therapy collab with Orchard

Pharming has sawed off its gene therapy collaboration with Orchard, a decision that will see the end of a preclinical hereditary angioedema program.
James Waldron May 8, 2024 6:15am
city sky stars sunset

With new data in hand, Astria makes ph. 3 wish on shooting star

Mar 25, 2024 10:46am
Photo of a person celebrating at the top of the mountain while the sun setsrises

KalVista's persistence with sebetralstat pays off in ph. 3 win

Feb 13, 2024 6:30am
On target clinical trial success bullseye score

Ionis’ HAE drug wins in phase 3 setting up approval run to FDA

Jan 22, 2024 9:34am
Go sign green light

FDA lifts remaining hold on Pharvaris’ HAE drug

Jan 22, 2024 7:32am
handshake deal shake hand arrows ok yes

Otsuka pays Ionis $65M for European rights to rare disease drug

Dec 19, 2023 10:18am